Developing a strategy to implement the NSF for Mental Health

2002-04-01T00:00:00+01:00

Topics

Formulary decision guide
Xaggitin XL (methylphenidate hydrochloride) prolonged-release tablets
Commissioned by Ethypharm UK Ltd
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-XAG-20 Date of preparation: July 2021
Top tips
Top tips: ADHD in children and young people
2021-07-30T11:14:00Z
Dr Natasha Halliwell offers 10 top tips on the identification and management of attention deficit hyperactivity disorder in children and young people
Test and reflect
Best practice in ADHD in children and young people
2021-07-30T11:00:00Z
The following questions written by Dr Natasha Halliwell relate to her article, Top tips: ADHD in children and young people, which offers 10 top tips on the identification and management of attention deficit hyperactivity disorder in children and young people.

You're not signed in.

Test and reflect
Patient scenarios: COVID-19-related mental ill health
2021-05-28T10:56:00Z
The following case studies, written by Dr Emma Nash, relate to her article, Managing COVID-19-related mental ill health in primary care.
Hot topic
Managing COVID-19-related mental ill health in primary care
2021-05-28T08:22:00Z
Dr Emma Nash discusses the challenges of assessing and addressing poor mental health in the context of COVID-19
Top tips
Top tips: learning disabilities and COVID-19
2020-12-22T12:38:00Z
Dr Claire Davies offers 10 top tips for primary care on caring for patients with learning disabilities during the COVID-19 pandemic, including preparing patients for winter